OptimizeRx(OPRX) - 2023 Q4 - Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Conference Call March 28, 2024 8:30 AM ET Company Participants William Febbo - CEO Edward Stelmakh - Chief Financial and Operating Officer Steve Silvestro - Chief Commercial Office Conference Call Participants Sean Dodge - RBC Capital Markets Stephanie Davis - Barclays William Wood - B. Riley Securities Operator Good morning, everyone and thank you for joining OptimizeRx’s Fourth Quarter Fiscal 2023 Conference Call. With us today is the Chief Executive O ...